AAAAAA

   
Results: 1-9 |
Results: 9
CLINICAL DECISION-MAKING IN BARRETTS-ESOPHAGUS CAN BE SUPPORTED BY COMPUTERIZED IMMUNOQUANTITATION AND MORPHOMETRY OF FEATURES ASSOCIATED WITH PROLIFERATION AND DIFFERENTIATION
Authors: POLKOWSKI W BAAK JPA VANLANSCHOT JJB MEIJER GA SCHUURMANS LT TENKATE FJW OBERTOP H OFFERHAUS GJA
Citation: W. Polkowski et al., CLINICAL DECISION-MAKING IN BARRETTS-ESOPHAGUS CAN BE SUPPORTED BY COMPUTERIZED IMMUNOQUANTITATION AND MORPHOMETRY OF FEATURES ASSOCIATED WITH PROLIFERATION AND DIFFERENTIATION, Journal of pathology, 184(2), 1998, pp. 161-168
QUANTITATIVE PATHOLOGICAL FEATURES IN SURVEILLANCE BIOPSIES OF BARRETT-ESOPHAGUS
Authors: VANSANDICK JW VANLANSCHOT JJB BAAK JPA POLKOWSKI W TENKATE FJW OBERTOP H OFFERHAUS GJA
Citation: Jw. Vansandick et al., QUANTITATIVE PATHOLOGICAL FEATURES IN SURVEILLANCE BIOPSIES OF BARRETT-ESOPHAGUS, Gastroenterology, 114(4), 1998, pp. 1314-1314
PROGNOSTIC VALUE OF LAUREN CLASSIFICATION AND C-ERBB-2 ONCOGENE OVEREXPRESSION IN ADENOCARCINOMA OF THE ESOPHAGUS AND GASTROESOPHAGEAL JUNCTION
Authors: POLKOWSKI W VANSANDICK JW OFFERHAUS GJA TENKATE FJW OBERTOP H VANLANSCHOT JJB
Citation: W. Polkowski et al., PROGNOSTIC VALUE OF LAUREN CLASSIFICATION AND C-ERBB-2 ONCOGENE OVEREXPRESSION IN ADENOCARCINOMA OF THE ESOPHAGUS AND GASTROESOPHAGEAL JUNCTION, Gastroenterology, 114(4), 1998, pp. 2736-2736
REPRODUCIBILITY OF P53 AND KI-67 IMMUNOQUANTITATION IN BARRETTS-ESOPHAGUS
Authors: POLKOWSKI W MEIJER GA BAAK JPA TENKATE FJW OBERTOP H OFFERHAUS GJA VANLANSCHOT JJB
Citation: W. Polkowski et al., REPRODUCIBILITY OF P53 AND KI-67 IMMUNOQUANTITATION IN BARRETTS-ESOPHAGUS, Analytical and quantitative cytology and histology, 19(3), 1997, pp. 246-254
COMPUTERIZED IMMUNOQUANTITATION AND MORPHOMETRY CAN SUPPORT CLINICAL DECISION-MAKING IN DYSPLASTIC BARRETTS MUCOSA
Authors: POLKOWSKI W BAAK JPA VANLANSCHOT JJB MEIJER GA SCHUURMANS LT TENKATE FJW OBERTOP H OFFERHAUS GJA
Citation: W. Polkowski et al., COMPUTERIZED IMMUNOQUANTITATION AND MORPHOMETRY CAN SUPPORT CLINICAL DECISION-MAKING IN DYSPLASTIC BARRETTS MUCOSA, Gastroenterology, 112(4), 1997, pp. 640-640
INTESTINAL AND PANCREATIC METAPLASIA AT THE GASTROESOPHAGEAL JUNCTIONIN PATIENTS WITHOUT BARRETT-ESOPHAGUS
Authors: POLKOWSKI W VANLANSCHOT JJB ROLF TM TYTGAT GNJ TENKATE FJW OBERTOP H OFFERHAUS GJA
Citation: W. Polkowski et al., INTESTINAL AND PANCREATIC METAPLASIA AT THE GASTROESOPHAGEAL JUNCTIONIN PATIENTS WITHOUT BARRETT-ESOPHAGUS, Gastroenterology, 112(4), 1997, pp. 640-640
THE VALUE OF P53 AND KI67 AS MARKERS FOR TUMOR PROGRESSION IN THE BARRETTS DYSPLASIA-CARCINOMA SEQUENCE
Authors: POLKOWSKI W VANLANSCHOT JJB TENKATE FJW BAAK JPA TYTGAT GNJ OBERTOP H VOORN WJ OFFERHAUS GJA
Citation: W. Polkowski et al., THE VALUE OF P53 AND KI67 AS MARKERS FOR TUMOR PROGRESSION IN THE BARRETTS DYSPLASIA-CARCINOMA SEQUENCE, Surgical oncology, 4(3), 1995, pp. 163-171
P53 AND KI67 AS MARKERS FOR TUMOR PROGRESSION IN THE BARRETTS METAPLASIA-DYSPLASIA-CARCINOMA SEQUENCE
Authors: POLKOWSKI W VANLANSCHOT JJB TENKATE FJW BAAK JPA TYTGAT GNJ OBERTOP H OFFERHAUS FJA
Citation: W. Polkowski et al., P53 AND KI67 AS MARKERS FOR TUMOR PROGRESSION IN THE BARRETTS METAPLASIA-DYSPLASIA-CARCINOMA SEQUENCE, Gastroenterology, 108(4), 1995, pp. 525-525
IS GASTRIC-CANCER HETEROGENEITY THE CLUE TO HLA-DR ASSOCIATED SUSCEPTIBILITY
Authors: SORY A GORSKI A MISIUNA P WALLNER G POLKOWSKI W
Citation: A. Sory et al., IS GASTRIC-CANCER HETEROGENEITY THE CLUE TO HLA-DR ASSOCIATED SUSCEPTIBILITY, Acta oncologica, 33(8), 1994, pp. 976-978
Risultati: 1-9 |